内镜下括约肌切开术

内镜下括约肌切开术的相关文献在1997年到2022年内共计60篇,主要集中在外科学、内科学、临床医学 等领域,其中期刊论文60篇、专利文献1066392篇;相关期刊45种,包括现代中西医结合杂志、基层医学论坛、现代诊断与治疗等; 内镜下括约肌切开术的相关文献由190位作者贡献,包括洪德飞、刘雄昌、吕农华等。

内镜下括约肌切开术—发文量

期刊论文>

论文:60 占比:0.01%

专利文献>

论文:1066392 占比:99.99%

总计:1066452篇

内镜下括约肌切开术—发文趋势图

内镜下括约肌切开术

-研究学者

  • 洪德飞
  • 刘雄昌
  • 吕农华
  • 周小江
  • 姚宝忠
  • 姜友
  • 张其勇
  • 张军
  • 李君达
  • 李国华
  • 期刊论文
  • 专利文献

搜索

排序:

年份

作者

    • 冯浩; 李顺宗; 王子伟
    • 摘要: 目的 比较腹腔镜胆总管探查术(LCBDE)与内镜下括约肌切开术(EST)联合腹腔镜胆囊切除术(LC)治疗胆囊结石合并胆总管结石患者的疗效及安全性.方法 2017年4月~2020年4月我院收治的150例胆囊结石合并胆总管结石患者,其中77例接受LCBDE联合LC治疗,另73例接受EST联合LC治疗,术后随访12个月.采用ELISA法检测血清白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α).结果 观察组手术时间和术中出血量分别为(143.3±17.7)min和(24.3±13.0)mL,显著长于或多于对照组[分别为(96.7±10.8)min和(16.7±7.2)mL,P0.05);术后2周,观察组胆瘘发生率为10.4%,显著高于对照组的1.4%(P<0.05),而胰腺炎和高淀粉酶血症发生率为2.6%和1.3%,显著低于对照组(分别为13.7%和16.4%,P<0.05).结论 采取LCBDE联合LC术治疗胆囊结石合并胆总管结石患者可能更有利于缩短患者住院时间,节省医疗费用,但两种手术方法清除结石的效果相似,临床可根据实际情况作出适当的选择.
    • 王建民
    • 摘要: 目的 探析对比胆总管结石开腹手术(OCHTD)与胆囊原位内镜下括约肌切开术(EST)临床价值。方法 选择2019年3月—2021年3月本院收治的89例胆囊结石后继发胆总管结石(CBDS)患者作为研究对象,随机分为对照组(43例)和观察组(46例)两组。对照组实施OCHTD,观察组于胆囊原位实施EST治疗,比较两组手术相关治疗指标、操作成功率、结石清除及复发率、括约肌功能指标(袖套式Oddi括约肌压力测定法(SOM)检测胆管压(CBDP)、收缩幅度(SOCA)以及收缩频率(SOF))、术式治疗安全性。结果 观察组手术、术后首次排气、康复住院时间及术中出血量、并发症发生率均明显低于对照组(P0.05)。结论 胆囊原位EST治疗胆囊结石后继发CBDS临床效果显著,与OCHTD具有相近结石清除率、复发率、操作成功率,不易对括约肌功能造成严重损伤,且可以有效缩短手术及康复时间,降低术中出血量,提高手术治疗效率及安全性,值得临床推广。
    • 袁学敏; 吴琼; 孔庆印; 姜开通; 王爱华; 谭鹏; 张秀田
    • 摘要: 目的 探讨胆总管结石治疗方法.方法 选取363例胆总管结石患者,将其随机分为EST组和EST-EPBD组.观察两组的取石成功率、机械碎石率、手术时间以及并发症发生率.结果 EST-EPBD组的取石成功率高于EST组(x2=18.15,P<0.01);机械碎石率、手术时间及近期出血率均低于EST组(P<0.01)结论EST-EPBD术治疗胆总管结石,成功率高,并发症少.
    • 张军; 李良; 李文波; 姜友; 姚宝忠; 杨仁保
    • 摘要: 目的 比较腹腔镜下胆总管切开取石术(LCBDE)和内镜下Oddis括约肌切开术(endoscopic sphincterotomy,EST)或内镜下十二指肠球囊扩张术(EPBD)治疗胆囊结石合并肝外胆管结石的疗效.方法 回顾性分析我院2011年1月至2017年5月行LCBDE治疗的48例胆总管结石患者临床资料,同期行LC+ EST(或EPBD)治疗的43例胆总管结石患者临床资料作为对照.结果 两组手术均无手术相关死亡发生.与LC+ EST组相比,LCBDE组术后急性胰腺炎发生率、结石残留率、严重并发症、住院时间、住院费用、手术出血量均明显降低,差异有统计学意义(P<0.05).结论 腹腔镜与十二指肠镜各自有相应的适应症,十二指肠镜适用于结石直径小,胆总管扩张不明显,或有上腹部手术史的患者,而腹腔镜联合胆道镜更有住院时间短,费用低,出血少,术后严重并发症发生率低、结石残留率低的优势.%Objective To compare the clinical effects between 1 aparoscopic cholecystectomy (LC) plus laparoscopic common bile duct exploration (LCBDE) and endoscopic sphincterotomy (EST) or endoscopic papillary balloon dilation (EPBD) in the treatment of cholecysto-choledocholithiasis.Methods the retrospectively cohort study was adopt.The clinical data of 81 patients with cholecysto-choledocholithiasis were selected from January 2011 to May 2017 for this study.Forty eight patients went LCBDE,43 others went EST or EPBD.Results The two groups have no mortality occurred post-operative.In compared with EST group,The acute pancreatitis occurrence rate、residual stones rate、postoperative hospital stay 、the medical cost and post-operative complications in LCBDE group were much better,and there was significant difference between two group statistically (P < 0.05).Conclusion the LCBDE and EST each have their respective indications.The EST was suitable for patients with small diameter of calculi、the inconspicuous bile duct expansion or with upper abdominal surgery.However,LCBDE has the advantage of low hospitalization time,low cost,low bleeding,low incidence of serious complications after operation,and low residual stones.
    • 郭晓明; 吴黄辉; 王丽萍; 吴晓智; 陈国忠; 谭钢
    • 摘要: Objective To investigate the anesthetic effect and adverse events on different doses of oxyco-done combined with propofol target controlled infusion(TCI)in patients with choledocholithiasis undergoing endo-scopic retrograde cholangio pancreatography(ERCP)with endoscopic sphincterotomy(EST).Methods One hun-dred and twenty patients with choledocholithiasis underwent ERCP with EST in Department of Gastroenterology, Fuzhou General Hospital,from January,2016 to March,2017 were enrolled in this study.Patients were randomly divided into 4 groups(n=30 in each group)including the sufentanil control group(Group A),low dose of oxyco-done group(Group B),moderate dose of oxycodone group(Group C),and high dose of oxycodone group(Group D).Patients in Group A received 0.10 μg/kg intravenous sufentanil,and patients in Group B,C,and D received 0.08 mg/kg,0.10 mg/kg,and 0.12 mg/kg intravenous oxycodone,respectively,at 5 min before induction of gener-al anesthesia followed by propofol TCI. Effect of compartment concentration(Ce)of propofol,mean arterial pres-sure(MAP),and heart rate(HR)at the given time point when patients transferring to operation room(T0),after induction(T1),endoscope through throat(T2),and endoscope through major duodenal papilla(T3)were record-ed.The accumulative dose of propofol,duration of operation,and recovery time were also recorded.Intraoperative sever hypotension,bradycardia,respiratory depression,coughing and moving,and postoperative nausea and vom-iting were recorded. Results Propofol Ce at T1~T3as well as MAP and HR at T2and T3in Group B were signifi-cantly higher than those in Group A,C,and D,respectively(P 0.05).结论 麻醉诱导前5 min静注0.10 mg/kg羟考酮复合丙泊酚靶控输注在ERCP合并EST中麻醉效果满意,且不延长苏醒时间,不增加麻醉相关不良事件发生率.
    • 戴璟瑜; 刘宜兵; 汤明生; 阎玉矿
    • 摘要: 目的 探讨分子生物学技术在内镜下括约肌切开术(EST)后患者胆道微生物群变化的应用研究.方法 选择EST术后反流性胆管炎患者40例作为实验对象,根据是否给予微生态制剂分为微生态制剂组20例,对照组20例,在给予微生态制剂2周后对所有患者胆汁标本采用变性梯度凝胶电泳技术(PCR-DGGE)和BioNumerics7.6软件分析胆道微生物菌群多样性.结果 微生态制剂组患者胆汁菌群Shannon-Weiner指数显著降低(P<0.05),但Simpson指数显著升高.结论微生态制剂组患者胆汁菌群的种类和数量明显低于对照组,能更好的降低EST反流性胆管炎患者炎症程度,从而减少抗生素的不合理应用.
    • 张军; 李良; 李文波; 姜友; 姚宝忠; 杨仁保
    • 摘要: 目的 比较腹腔镜下胆总管切开取石术(LCBDE)与LC联合内镜下Oddis括约肌切开术(endoscopic sphincterotomy,EST)或内镜下十二指肠球囊扩张术(EPBD)治疗胆囊结石合并肝外胆管结石的疗效.方法 回顾性分析我院2011年1月至2017年5月行LCBDE治疗的48例胆总管结石患者临床资料,同期行LC+ EST(或EPBD)治疗的43例胆总管结石患者临床资料作为对照.结果 两组手术均无手术相关死亡发生.与LC+ EST组相比,LCBDE组术后急性胰腺炎发生率、结石残留率、严重并发症、住院时间、住院费用、手术出血量均明显降低,差异有统计学意义(P<0.05).结论 腹腔镜与十二指肠镜各自有相应的适应症,十二指肠镜适用于结石直径小,胆总管扩张不明显,或有上腹部手术史的患者,而腹腔镜联合胆道镜更有住院时间短,费用低,出血少,术后严重并发症发生率低、结石残留率低的优势.%Objective To compare the clinical effects between 1 aparoscopic cholecystectomy (LC) plus laparoscopic common bile duct exploration (LCBDE) and endoscopic sphincterotomy (EST) or endoscopic papillary balloon dilation(EPBD) in the treatment of cholecysto-choledocholithiasis.Methods The retrospectively cohort study was adopt.The clinical data of 81 patients with cholecysto-choledocholithiasis were selected from January 2011 to May 2017 for this study.Forty eight patients went LCBDE,43 others went EST or EPBD.Results The two groups have no mortality occurred post-operative.In compared with EST group,The acute pancreatitis occurrence rate、residual stones rate、postoperative hospital stay 、the medical cost and post-operative complications in LCBDE group were much better,and there was significant difference between two group statistically (P < 0.05).Conclusion the LCBDE and EST each have their respective indications.The EST was suitable for patients with small diameter of calculi、the inconspicuous bile duct expansion or with upper abdominal surgery.However,LCBDE has the advantage of low hospitalization time,low cost,low bleeding,low incidence of serious complications after operation,and low residual stones.
    • 王春丽
    • 摘要: 目的 观察腹腔镜胆囊切除术(LC)术前行经内镜逆行性胰胆管造影术(ERCP)+内镜下括约肌切开术(EST)治疗高龄胆囊结石合并胆总管结石患者的近期疗效.方法 选取确诊为胆囊结石合并胆总管结石拟行LC及ERCP+ EST患者80例作为研究对象,按照随机数字表法分为研究组和对照组,每组40例,其中研究组治疗方案为LC术前行ERCP+EST,对照组治疗方案为LC术后行ERCP+EST,观察两组患者围术期情况、肝功能指标及并发症发生率.结果 两组患者术中出血量、取石成功率及住院、排气、平均手术时间差异无统计学意义(P>0.05);两组患者术后3d总胆红素、丙氨酸氨基转移酶、碱性磷酸酶、血浆清蛋白水平与术前1d比较差异有统计学意义(P<0.05);研究组并发症发生率为7.50%,低于对照组的17.50% (P<0.05).结论 LC术前行ERCP+EST治疗高龄胆囊结石合并胆总管结石可有效降低并发症,提高临床治疗效果.
    • 沈晖; 王陆军; 田所礼
    • 摘要: 目的 对LCBDE+LC(腹腔镜胆总管探查术+腹腔镜胆囊切除术)与EST+LC(内镜下括约肌切开术+腹腔镜胆囊切除术)治疗肝外胆管结石的临床效果进行比较.方法 选取2013年11月~2016年3月我院收治的80例肝外胆管结石患者.根据患者所接受的手术操作方法分为观察组和对照组各40例.观察组行LCBDE+LC治疗,对照组行EST+LC治疗,比较2组患者临床疗效.结果 观察组手术时间、术中出血量、住院时间显著短于对照组,两组比较差异显著(P0.05).结论 与LCBDE+LC相比,EST+LC治疗肝外胆管结石,在缩短手术时间、减少住院时间、降低术中出血量上的临床效果更为显著,值得临床推广.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号